{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:07:05Z","timestamp":1762664825152,"version":"build-2065373602"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.remnie.2025.500160","type":"journal-article","created":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T12:02:27Z","timestamp":1750420947000},"page":"500160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Staging in nasopharynx cancers prognostic value of volumetric parameters in [18F]FDG PET\/CT imaging"],"prefix":"10.1016","volume":"44","author":[{"given":"\u00c7.","family":"Erol","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6.","family":"\u015eahin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Kany\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Erol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.remnie.2025.500160_bib0005","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1158\/1055-9965.EPI-06-0353","article-title":"The enigmatic epidemiology of nasopharyngeal carcinoma","volume":"15","author":"Chang","year":"2006","journal-title":"Cancer Epidemiol Biomark Prev"},{"key":"10.1016\/j.remnie.2025.500160_bib0010","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ijrobp.2005.12.003","article-title":"Nasopharyngeal carcinoma treated by radical radiotherapy alone: ten-year experience of a single institution","volume":"65","author":"Yi","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.remnie.2025.500160_bib0015","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1470-2045(15)70126-9","article-title":"Chemotherapy and radiotherapy in nasopharyngeal carcinoma: an update of the MAC-NPC meta-analysis","volume":"16","author":"Blanchard","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0020","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1007\/s12149-022-01770-4","article-title":"Pretreatment [18F] FDG PET\/CT and MRI in the prognosis of nasopharyngeal carcinoma","volume":"36","author":"Gihbid","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/j.remnie.2025.500160_bib0025","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S1535-6108(04)00119-9","article-title":"Focus on nasopharyngeal carcinoma","volume":"5","author":"Lo","year":"2004","journal-title":"Cancer Cell"},{"key":"10.1016\/j.remnie.2025.500160_bib0030","doi-asserted-by":"crossref","first-page":"13612","DOI":"10.18632\/oncotarget.7253","article-title":"Establishment of an integrated model incorporating standardised uptake value and N-classification for predicting metastasis in nasopharyngeal carcinoma","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.remnie.2025.500160_bib0035","doi-asserted-by":"crossref","first-page":"16","DOI":"10.7812\/TPP\/16-180","article-title":"Nasopharyngeal carcinoma diagnostic challenge in a nonendemic setting: our experience with 101 patients","volume":"21","author":"Wang","year":"2017","journal-title":"Perm J"},{"key":"10.1016\/j.remnie.2025.500160_bib0040","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.radonc.2006.03.012","article-title":"Dose\u2013response relationship of nasopharyngeal carcinoma above conventional tumoricidal level: a study by the Hong Kong nasopharyngeal carcinoma study group (HKNPCSG)","volume":"79","author":"Teo","year":"2006","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0045","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1007\/s00259-008-0918-7","article-title":"Staging of untreated nasopharyngeal carcinoma with PET\/CT: comparison with conventional imaging work-up","volume":"36","author":"Ng","year":"2009","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500160_bib0050","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.radonc.2008.01.009","article-title":"Prediction of prognosis using standardized uptake value of 2-[(18)F] fluoro-2-deoxy-d-glucose positron emission tomography for nasopharyngeal carcinomas","volume":"87","author":"Lee","year":"2008","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0055","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.oraloncology.2008.03.010","article-title":"Prediction for distant failure in patients with stage M0 nasopharyngeal carcinoma: the role of standardized uptake value","volume":"45","author":"Chan","year":"2009","journal-title":"Oral Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.104756","article-title":"Lymph node-to-primary tumor standardized uptake value ratio on PET predicts distant metastasis in nasopharyngeal carcinoma","volume":"110","author":"Hung","year":"2020","journal-title":"Oral Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0065","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1200\/JCO.21.02063","article-title":"Proposed new dynamic prognostic index for diffuse large B-cell lymphoma: international metabolic prognostic index","volume":"40","author":"Mikhaeel","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0070","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00259-017-3805-2","article-title":"Prognostic value of lymph node-to-primary tumor standardized uptake value ratio in endometrioid endometrial carcinoma","volume":"45","author":"Chung","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.remnie.2025.500160_bib0075","doi-asserted-by":"crossref","first-page":"6841","DOI":"10.1002\/cam4.2481","article-title":"Combining pretreatment plasma Epstein-Barr virus DNA level and cervical node necrosis improves prognostic stratification in patients with nasopharyngeal carcinoma: a cohort study","volume":"8","author":"Du","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/j.remnie.2025.500160_bib0080","doi-asserted-by":"crossref","first-page":"W146","DOI":"10.2214\/AJR.13.12420","article-title":"FDG PET\/CT in the management of nasopharyngeal carcinoma","volume":"203","author":"Mohandas","year":"2014","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.remnie.2025.500160_bib0085","first-page":"367","article-title":"Prognostic value of primary tumor and lymph node volumetric metabolic parameters at pre-treatment F-18 FDG PET\/CT in nasopharyngeal carcinoma","volume":"42","author":"Demirel","year":"2023","journal-title":"Rev Esp Med Nucl Imagen Mol (Engl Ed)"},{"key":"10.1016\/j.remnie.2025.500160_bib0090","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000016327","article-title":"Metabolic tumor volume and conformal radiotherapy based on prognostic PET\/CT for treatment of nasopharyngeal carcinoma","volume":"98","author":"Fei","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.remnie.2025.500160_bib0095","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/annonc\/mdp430","article-title":"Prognostic value of 18F-FDG PET\/CT before and after radiotherapy for locally advanced nasopharyngeal carcinoma","volume":"21","author":"Xie","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0100","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3342\/ceo.2015.8.2.142","article-title":"Prognostic value of volume-based positron emission tomography\/computed tomography in patients with nasopharyngeal carcinoma treated with concurrent chemoradiotherapy","volume":"8","author":"Moon","year":"2015","journal-title":"Clin Exp Otorhinolaryngol"},{"key":"10.1016\/j.remnie.2025.500160_bib0105","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2967\/jnumed.111.090696","article-title":"Prognostic significance of 18F-FDG PET parameters and plasma Epstein-Barr virus DNA load in patients with nasopharyngeal carcinoma","volume":"53","author":"Chang","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500160_bib0110","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1002\/alr.21363","article-title":"Prognostic value of metabolic tumor volume as measured by fluorine-18-fluorodeoxyglucose positron emission tomography\/computed tomography in nasopharyngeal carcinoma","volume":"4","author":"Yoon","year":"2014","journal-title":"Int Forum Allergy Rhinol"},{"key":"10.1016\/j.remnie.2025.500160_bib0115","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S1470-2045(11)70320-5","article-title":"Concurrent chemoradiotherapy plus adjuvant chemotherapy versus concurrent chemoradiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma: a phase 3 multicentre randomised controlled trial","volume":"13","author":"Chen","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0120","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/RLU.0b013e31821a29a4","article-title":"Prognostic impact of standardized uptake value of F-18 FDG PET\/CT in nasopharyngeal carcinoma","volume":"36","author":"Chan","year":"2011","journal-title":"Clin Nucl Med"},{"key":"10.1016\/j.remnie.2025.500160_bib0125","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/1450-1147.181151","article-title":"Prognostic significance of standardized uptake value on (18)fluorine-fluorodeoxyglucose positron emission tomography\/computed tomography in patients with nasopharyngeal carcinoma","volume":"16","author":"T\u00fcrk\u00f6lmez","year":"2017","journal-title":"World J Nucl Med"},{"key":"10.1016\/j.remnie.2025.500160_bib0130","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2013.10.007","article-title":"Prognostic value of parapharyngeal extension in nasopharyngeal carcinoma treated with intensity modulated radiotherapy","volume":"110","author":"Tang","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0135","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1259\/0007-1285-63-745-51","article-title":"Prognostic factors of nasopharyngeal carcinoma: a review of 759 patients","volume":"63","author":"Sham","year":"1990","journal-title":"Br J Radiol"},{"key":"10.1016\/j.remnie.2025.500160_bib0140","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.radonc.2012.09.001","article-title":"Is primary tumor volume still a prognostic factor in intensity modulated radiation therapy for nasopharyngeal carcinoma?","volume":"104","author":"Guo","year":"2012","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.remnie.2025.500160_bib0145","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1186\/s12885-020-07044-4","article-title":"Prognostic value of lymph node to primary tumor standardized uptake value ratio in unresectable esophageal cancer","volume":"20","author":"Chen","year":"2020","journal-title":"BMC Cancer"},{"key":"10.1016\/j.remnie.2025.500160_bib0150","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s00405-022-07562-w","article-title":"The prognostic value of the ratio of standard uptake value of lymph node to primary tumor before treatment of locally advanced nasopharyngeal carcinoma","volume":"280","author":"Lou","year":"2023","journal-title":"Eur Arch Otorhinolaryngol"}],"container-title":["Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000941?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2253808925000941?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T05:05:16Z","timestamp":1762664716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2253808925000941"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2253808925000941"],"URL":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500160","relation":{},"ISSN":["2253-8089"],"issn-type":[{"type":"print","value":"2253-8089"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staging in nasopharynx cancers prognostic value of volumetric parameters in [18F]FDG PET\/CT imaging","name":"articletitle","label":"Article Title"},{"value":"Revista Espa\u00f1ola de Medicina Nuclear e Imagen Molecular (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.remnie.2025.500160","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.remn.2025.500160","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Sociedad Espa\u00f1ola de Medicina Nuclear e Imagen Molecular. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"500160"}}